Sandoz Appoints Dragos Toma to Lead Egypt and Libya Operations

Sandoz, a prominent player in the pharmaceutical industry, has announced the appointment of Dragos Toma as Country Head for Egypt and Libya. With over 21 years of experience in the industry, Toma brings extensive expertise in business leadership, healthcare policy, and expanding patient access to medicines. His appointment comes as Sandoz continues to strengthen its presence in Egypt, where the company leads in biosimilars and offers a broad portfolio of generic and essential medicines.

Dragos Toma joins Sandoz with a rich background, having spent over 13 years with the company. Most recently, he headed the Biosimilars and Prescription Medicines Business Unit at Sandoz Romania and served as Interim Country Head in Romania. His experience includes engagement in national healthcare policy discussions on biosimilar prescribing, uptake, and patient access. Toma's professional interests include talent development, collaborative leadership, and improving access to medicines.

Before joining Sandoz in 2013, Dragos Toma began his pharmaceutical career with Menarini Group in 2004, followed by Ranbaxy. He holds a bachelor's degree in law and has pursued a postgraduate business education through the Open University Business School. Toma is also a proud graduate of the Sandoz "General Management Academy" program at HEC in Paris. His educational background and professional experience equip him to lead Sandoz's operations in Egypt and Libya.

Sandoz has a strong presence in Egypt, leading in biosimilars and offering a broad portfolio of generic and essential medicines. The company continues to advance local manufacturing and technology transfer in the region. With Toma at the helm, Sandoz aims to build on its established position and partnerships in Egypt and Libya. Toma expressed his enthusiasm for the role, stating that Egypt and Libya offer important opportunities to strengthen local capabilities and help more patients access the medicines they need.

Dragos Toma's appointment is seen as a strategic move to drive growth and expansion in the region. He will work closely with Sandoz's teams, authorities, healthcare professionals, and stakeholders to achieve the company's goals. Toma's experience in business leadership and healthcare policy will be instrumental in navigating the complexities of the pharmaceutical industry in Egypt and Libya.

Sandoz's commitment to improving access to medicines is reflected in Toma's professional interests. He aims to work collaboratively with stakeholders to strengthen local capabilities and enhance patient access to medicines. The company's focus on biosimilars and generic medicines aligns with its goal of providing affordable and high-quality healthcare solutions to patients in Egypt and Libya.

Commenting on his appointment, Dragos Toma said, "Egypt and Libya offer important opportunities to build on Sandoz's established presence and partnerships. I look forward to working with our teams, authorities, healthcare professionals, and stakeholders to strengthen local capabilities and help more patients access the medicines they need." With Toma's leadership, Sandoz is poised to continue its growth and expansion in the region, driven by its commitment to improving patient access to medicines.

Key points

• Dragos Toma has over 21 years of experience in the pharmaceutical industry, including over 13 years at Sandoz.
• Sandoz leads in biosimilars in Egypt and offers a broad portfolio of generic and essential medicines.
• Toma's professional interests include talent development, collaborative leadership, and improving access to medicines.